DIA Labs is transforming asthma care with AirSense, an affordable and comfortable wearable device designed for continuous, real-time monitoring. Backed by provincial-level funding, AirSense provides accurate lung function data that integrates seamlessly with smartphones, empowering patients to stay in control of their condition. Its advanced AI-driven insights help predict asthma flare-ups, offering timely interventions. Not only is AirSense improving daily asthma management, but it’s also providing precise, real-world data that will be invaluable for advancing clinical trials. DIA Labs is committed to delivering innovative, cost-effective solutions for better respiratory health.
Director
Chief Scientific Officer
Manager of Strategic Business Partnerships and Regulatory Affairs
Intellectual Property
Fundraising
Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?
The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.
Applications are open from June 16 to July 7, 2025.
